🇺🇸 Unfractionated heparin(UFH) in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 32

Most-reported reactions

1. Haemorrhage — 9 reports (28.12%)
2. Embolism — 7 reports (21.88%)
3. Product Use In Unapproved Indication — 4 reports (12.5%)
4. Drug Exposure During Pregnancy — 2 reports (6.25%)
5. Injection Site Erythema — 2 reports (6.25%)
6. Injection Site Inflammation — 2 reports (6.25%)
7. Injection Site Pruritus — 2 reports (6.25%)
8. Rash — 2 reports (6.25%)
9. Haemorrhage Intracranial — 1 report (3.12%)
10. Off Label Use — 1 report (3.12%)

Source database →

Frequently asked questions

Is Unfractionated heparin(UFH) approved in United States?

Unfractionated heparin(UFH) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Unfractionated heparin(UFH) in United States?

Beijing Chao Yang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.